ENvue Medical, Inc. (FEED)
NASDAQ: FEED · Real-Time Price · USD
3.660
+1.360 (59.13%)
Jan 29, 2026, 10:57 AM EST - Market open

Company Description

ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance.

The company’s product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.

It also provides UroShield Ultra, which is designed to prevent bacterial colonization and biofilm formation in urinary catheters; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures.

In addition, it provides PainShield MD, a single patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; PainShield Plus, a dual patch-based therapeutic ultrasound technology; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing.

It sells its products directly to patients, as well as through distributor agreements in the United States, Europe, Australia, Israel, New Zealand, and internationally.

The company was formerly known as NanoVibronix, Inc. and changed its name to ENvue Medical, Inc. in December 2025.

ENvue Medical, Inc. was incorporated in 2003 and is based in Tyler, Texas.

ENvue Medical, Inc.
CountryUnited States
Founded2003
IndustryMedical Devices
SectorHealthcare
Employees31
CEODoron Besser

Contact Details

Address:
969 Pruitt Ave
Tyler, Texas 77569
United States
Phone914 233 3004
Websiteenvuemed.com

Stock Details

Ticker SymbolFEED
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001326706
CUSIP Number63008J884
ISIN NumberUS63008J8844

Key Executives

NamePosition
Dr. Doron Robert Besser M.D.Chief Executive Officer and Director
Stephen R. Brown CPAChief Financial Officer
Dr. Harold Jacob M.D.Chief Medical Officer
Rita SilberbergExecutive Vice President of Finance, Chief Accounting Officer and Corporate Secretary
Lindsey HarrisonVice President of Sales